Decode and design the interfaces of life
Location: United States
Total raised: $80M
Investors 1
| Date | Name | Website |
| 03.02.2026 | Roivant | roivant.co... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 13.01.2026 | Seed | $80M | Magnetic V... |
Mentions in press and media 3
| Date | Title | Description |
| 17.01.2026 | Proxima Secures $80M Seed Round to Redefine Drug Discovery | Proxima, an AI-native biotech firm, secured an $80 million seed funding round. DCVC led the investment. NVentures and other major investors participated. Formerly VantAI, the company now targets proximity therapeutics. It aims to revolution... |
| 13.01.2026 | Proxima Raises $80M in Seed Funding | Proxima (formerly VantAI), a NYC-based AI-native biotech company developing AI-driven drug discovery for proximity therapeutics, raised $80M in Seed funding. The round was led by DCVC, with participation from NVentures (NVIDIA’s venture cap... |
| - | Proxima | - |